NO20064834L - Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer. - Google Patents

Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer.

Info

Publication number
NO20064834L
NO20064834L NO20064834A NO20064834A NO20064834L NO 20064834 L NO20064834 L NO 20064834L NO 20064834 A NO20064834 A NO 20064834A NO 20064834 A NO20064834 A NO 20064834A NO 20064834 L NO20064834 L NO 20064834L
Authority
NO
Norway
Prior art keywords
compositions
torasmid
forming polymer
prolonged release
matrix forming
Prior art date
Application number
NO20064834A
Other languages
English (en)
Other versions
NO336582B1 (no
Inventor
Marta Guerrero
Alfonso Romero
Antonio Guglietta
Original Assignee
Ferrer Internat Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34962072&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20064834(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Internat Sa filed Critical Ferrer Internat Sa
Publication of NO20064834L publication Critical patent/NO20064834L/no
Publication of NO336582B1 publication Critical patent/NO336582B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Diuretiske preparater med forlenget frigivningsvirkning inneholdende torasemid som aktiv bestanddel. Preparatene ifølge oppfinnelsen er nyttige idet de gjør at plagsomme hyppige urinlatninger forårsaket av konvensjonelle preparater med umiddelbar frigivningsvirkning unngås.
NO20064834A 2004-03-25 2006-10-24 Preparater med forlenget frigivning innbefattende torasemid, en matriksdannende polymer og laktose NO336582B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400740A ES2244324B1 (es) 2004-03-25 2004-03-25 Composiciones diureticas de liberacion prolongada.
PCT/EP2005/051340 WO2005092291A1 (en) 2004-03-25 2005-03-23 Prolonged-release compositions comprising torasemide and a matrix-forming polymer

Publications (2)

Publication Number Publication Date
NO20064834L true NO20064834L (no) 2006-12-07
NO336582B1 NO336582B1 (no) 2015-09-28

Family

ID=34962072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064834A NO336582B1 (no) 2004-03-25 2006-10-24 Preparater med forlenget frigivning innbefattende torasemid, en matriksdannende polymer og laktose

Country Status (20)

Country Link
US (1) US20080187585A1 (no)
EP (1) EP1732517B1 (no)
JP (1) JP4871258B2 (no)
KR (1) KR101203763B1 (no)
CN (1) CN1946379B (no)
AR (1) AR048432A1 (no)
AU (1) AU2005227095B2 (no)
BR (1) BRPI0509165A (no)
CA (1) CA2562142C (no)
ES (2) ES2244324B1 (no)
MX (1) MXPA06010833A (no)
NO (1) NO336582B1 (no)
PA (1) PA8627401A1 (no)
PE (1) PE20060015A1 (no)
PL (1) PL1732517T3 (no)
PT (1) PT1732517T (no)
RU (2) RU2006137671A (no)
TW (1) TWI351957B (no)
UY (1) UY28809A1 (no)
WO (1) WO2005092291A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10596119B1 (en) * 2018-11-08 2020-03-24 Sarfez Pharmaceuticals, Inc. Methods of treatment comprising torsemide
US10154963B2 (en) * 2013-10-06 2018-12-18 Sarfez Pharmaceuticals, Inc. Controlled-release formulations comprising Torsemide
US10463622B2 (en) * 2013-10-06 2019-11-05 Sarfez Pharmaceuticals, Inc. Treatments and formulations comprising Torsemide
EP3031471A1 (en) * 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
JP2003527319A (ja) * 1999-08-11 2003-09-16 テバ ファーマシューティカル インダストリーズ リミティド トルセミド多形体
DE60103276T2 (de) * 2000-02-17 2005-06-23 Teva Pharmaceutical Industries Ltd. Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
US20030119882A1 (en) * 2001-10-22 2003-06-26 Markus Maegerlein Solid pharmaceutical composition containing torasemide
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
EP1691790A1 (en) * 2003-12-12 2006-08-23 Penwest Pharmaceuticals Company Sustained release torsemide dosage forms

Also Published As

Publication number Publication date
TW200531693A (en) 2005-10-01
TWI351957B (en) 2011-11-11
PT1732517T (pt) 2017-08-03
JP4871258B2 (ja) 2012-02-08
AU2005227095B2 (en) 2010-10-28
AU2005227095A1 (en) 2005-10-06
RU2449778C1 (ru) 2012-05-10
ES2632354T3 (es) 2017-09-12
UY28809A1 (es) 2005-07-29
PE20060015A1 (es) 2006-02-02
MXPA06010833A (es) 2006-12-15
PA8627401A1 (es) 2005-11-25
US20080187585A1 (en) 2008-08-07
KR101203763B1 (ko) 2012-11-23
CA2562142A1 (en) 2005-10-06
RU2006137671A (ru) 2008-04-27
CN1946379A (zh) 2007-04-11
AR048432A1 (es) 2006-04-26
ES2244324A1 (es) 2005-12-01
EP1732517A1 (en) 2006-12-20
JP2007530510A (ja) 2007-11-01
NO336582B1 (no) 2015-09-28
ES2244324B1 (es) 2006-11-16
EP1732517B1 (en) 2017-05-03
CN1946379B (zh) 2012-05-16
KR20060130756A (ko) 2006-12-19
WO2005092291A1 (en) 2005-10-06
PL1732517T3 (pl) 2017-09-29
CA2562142C (en) 2012-06-05
BRPI0509165A (pt) 2007-09-11

Similar Documents

Publication Publication Date Title
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
DE602006002260D1 (de) Insektenabweisende zusammensetzungen mit verzögerter freisetzung
NO20091395L (no) Nye tiofenderivater
WO2005123076A3 (en) Pharmaceutical compositions
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
UA94065C2 (en) Dihydropseudoerythromycin derivatives
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
NO20083630L (no) Nye pyridinderivater
TW200738670A (en) Novel thiophene derivatives
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
GEP20135803B (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
NO20071667L (no) Farmasoytisk preparat omfattende levetiracetam og fremgangsmate for fremstilling av preparatet
MY154909A (en) Novel thiophene derivatives
TW200716628A (en) Novel compounds
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MA28999B1 (fr) Compositions destinees a lutter contre un ou plusieurs pathogenes
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
NO20071095L (no) Hittil ukjente tiofenderivater
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
WO2008006528A3 (en) Pharmaceutical compositions comprising levetiracetam
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees